Mechanopriming by vascular stiffness and phenotypic reprogramming by disturbed flow: mechanobiology and clinical translation in atherosclerosis - Report - MDSpire

Mechanopriming by vascular stiffness and phenotypic reprogramming by disturbed flow: mechanobiology and clinical translation in atherosclerosis

  • By

  • Jin He

  • Jun Meng

  • June 24, 2026

  • 0 min

Share

Vascular Stiffness and Disturbed Flow-Induced Phenotypic Reprogramming

Overview

This review discusses the role of disturbed flow and vascular stiffness in atherosclerosis, emphasizing their impact on endothelial cell reprogramming and plaque progression. It highlights the molecular mechanisms involved.

Background

Atherosclerosis is a leading cause of cardiovascular morbidity and mortality, characterized by localized plaque formation at arterial bifurcations and curvatures. Understanding the mechanical factors, such as fluid shear stress and vascular stiffness, is crucial for elucidating the disease's pathogenesis.

Data Highlights

No numerical data presented in the article.

Key Findings

  • Fluid shear stress and vascular wall stiffness are critical in atherosclerotic plaque progression.
  • Disturbed flow (DF) and oscillatory shear stress (OSS) lead to pathological reprogramming of endothelial cells.
  • Mechanisms include cGAS-STING-mediated senescence, NLRP3-driven pyroptosis, and endothelial-to-mesenchymal transition (EndoMT).
  • The Piezo1 ion channel and 5-HT1B receptor act as coincidence detectors for shear stress and matrix stiffness signals.
  • Emerging imaging techniques and computational fluid dynamics enhance the assessment of wall shear stress in vivo.
  • Potential therapeutic strategies include mechanodrugs and hemodynamic stent optimization.

Clinical Implications

The findings indicate that localized hemodynamic parameters should be integrated into clinical risk stratification models for atherosclerosis.

Conclusion

This review discusses mechanical factors in atherosclerosis.

Related Resources & Content

  1. Tertiary Lymphoid Structures in Arteries: Neuro-Immune Interactions and Their Role in Atherosclerosis, 2026 -- https://link.springer.com/article/10.1007/s00395-026-01164-x
  2. Vascular endothelial integration of multiple biophysical stimuli, Frontiers in Cardiovascular Medicine, 2026 -- https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1866905/full
  3. The Impact of Heterogeneity in Capillary Transit Time on Myocardial Oxygen Supply and Ischemic Heart Disease, Basic Research in Cardiology, 2014 -- https://link.springer.com/article/10.1007/s00395-014-0409-x
  4. The Importance of Endothelial Resilience in Sustaining Cardiac Health, Basic Research in Cardiology, 2022 -- https://link.springer.com/article/10.1007/s00395-022-00941-8
  5. ACC, AHA Release New Clinical Guideline For Managing Dyslipidemia, American College of Cardiology, 2026 -- https://www.acc.org/latest-in-cardiology/journal-scans/2026/03/13/15/20/acc-aha-release-new-clinical-guideline-for-managing-dyslipidemia
  6. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke, New England Journal of Medicine -- https://www.nejm.org/doi/abs/10.1056/NEJMoa2514428?utm_source=openai
  7. ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points, PubMed -- https://pubmed.ncbi.nlm.nih.gov/41001923/?utm_source=openai
  8. ACC, AHA Release New Clinical Guideline For Managing Dyslipidemia - American College of Cardiology
  9. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke | New England Journal of Medicine
  10. ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points - PubMed

Original Source(s)

Related Content